Prevention of radiotherapy side-effects by early hyperbaric oxygen administration.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON22762

Enrollment

180

Registered

2006-03-03

Start date

2006-02-06

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oropharyngeal and nasopharyngeal cancer

Interventions

Randomisation of Hyperbaric Oxygen (one group with and one group without). Treatment consists of 30 sessions of 2 hours a day.

Eligibility

Inclusion criteria

Inclusion criteria: 1. Curative intent; 2. Presence of oropharynx en nasopharynx tumours.

Exclusion criteria

Exclusion criteria: Palliative treatment.

Design outcomes

Primary

Measure	Time frame
1. Xerostomia; 2. Mucositis; 3. Trismus.	—

Secondary

Measure	Time frame
1. Tumor control; 2. Quality of Life.	—

Contacts

Public ContactP.C. Levendag

Erasmus Medical Center, Department of Radiotherapy, Groenehilledijk 301

p.levendag@erasmusmc.nl

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)